| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Human Anatomy and Physiology, Sections of Anatomy (G.M., L.K.M., L.G., G.G.N.) and Urology (F.A.), University of Padua, I-35121 Padua, Italy
Address all correspondence and requests for reprints to: Prof. G. Mazzocchi, Department of Human Anatomy and Physiology, Section of Anatomy, Via Gabelli 65, I-35121 Padova, Italy. E-mail: mazzocch{at}ux1.unipd.it
Orexins A and B are two hypothalamic peptides that increase food intake and body weight and probably play a role in the sleep regulation. They act through two subtypes of G protein-coupled receptors, called OX1-R and OX2-R. OX1-R selectively binds orexin-A, whereas OX2-R is nonselective for both orexins. Orexins did not affect the in vitro secretion of either catecholamine or aldosterone from human adrenals. Conversely, orexin A, but not orexin B, concentration dependently increased basal cortisol secretion from dispersed adrenocortical cells; the maximal effective concentration was 10-8 mol/L. Orexin A (10-8 mol/L) enhanced the cortisol response to maximal effective concentrations (10-9 mol/L) of angiotensin II and endothelin-1, but only to low concentrations of ACTH (10-12/10-11 mol/L). Orexin A (10-8 mol/L) increased basal cAMP release by dispersed adrenocortical cells, and the effect was blocked by the adenylate cyclase inhibitor SQ-22536. The cortisol response to 10-8 mol/L orexin A was unaffected by the ACTH receptor antagonist corticotropin-inhibiting peptide, but was abolished by either SQ-22536 or the protein kinase A inhibitor H-89. RT-PCR demonstrated high levels of OX1-R messenger ribonucleic acid and very low levels of OX2-R messenger ribonucleic acid in human adrenal zona fasciculata-reticularis and adrenal medulla. Collectively, our findings suggest that orexins selectively stimulate glucocorticoid secretion from human adrenocortical cells, acting through OX1-R coupled with the adenylate cyclase-dependent signaling pathway.
This article has been cited by other articles:
![]() |
J. Wenzel, N. Grabinski, C. A. Knopp, A. Dendorfer, M. Ramanjaneya, H. S. Randeva, M. Ehrhart-Bornstein, P. Dominiak, and O. Johren Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1601 - R1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramanjaneya, A. C Conner, J. Chen, P. Kumar, J. E P Brown, O. Johren, H. Lehnert, P. R Stanfield, and H. S Randeva Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B J. Endocrinol., August 1, 2009; 202(2): 249 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramanjaneya, A. C. Conner, J. Chen, P. R. Stanfield, and H. S. Randeva Orexins Stimulate Steroidogenic Acute Regulatory Protein Expression through Multiple Signaling Pathways in Human Adrenal H295R Cells Endocrinology, August 1, 2008; 149(8): 4106 - 4115. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Goncz, M. Z. Strowski, C. Grotzinger, K. W. Nowak, P. Kaczmarek, M. Sassek, S. Mergler, B. F. El-Zayat, M. Theodoropoulou, G. K. Stalla, et al. Orexin-A Inhibits Glucagon Secretion and Gene Expression through a Foxo1-Dependent Pathway Endocrinology, April 1, 2008; 149(4): 1618 - 1626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Yang, H. C. Parkington, J. Epelbaum, D. J. Keating, and C. Chen Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2 Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1863 - E1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Samson, S. L. Bagley, A. V. Ferguson, and M. M. White Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R382 - R387. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Digby, J Chen, J Y Tang, H Lehnert, R N Matthews, and H S Randeva Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J. Endocrinol., October 1, 2006; 191(1): 129 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol. Rev., March 1, 2006; 58(1): 46 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spinazzi, M. Rucinski, G. Neri, L. K. Malendowicz, and G. G. Nussdorfer Preproorexin and Orexin Receptors Are Expressed in Cortisol-Secreting Adrenocortical Adenomas, and Orexins Stimulate in Vitro Cortisol Secretion and Growth of Tumor Cells J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3544 - 3549. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mazzocchi, P. Rebuffat, A. Ziolkowska, G. P. Rossi, L. K. Malendowicz, and G. G. Nussdorfer G Protein Receptors 7 and 8 Are Expressed in Human Adrenocortical Cells, and Their Endogenous Ligands Neuropeptides B and W Enhance Cortisol Secretion by Activating Adenylate Cyclase- and Phospholipase C-Dependent Signaling Cascades J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3466 - 3471. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karteris, R. J. Machado, J. Chen, S. Zervou, E. W. Hillhouse, and H. S. Randeva Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1089 - E1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. van Aken, A. M Pereira, S. W. van Thiel, G. van den Berg, M. Frolich, J. D. Veldhuis, J. A. Romijn, and F. Roelfsema Irregular and Frequent Cortisol Secretory Episodes with Preserved Diurnal Rhythmicity in Primary Adrenal Cushing's Syndrome J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1570 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Holmqvist, L. Johansson, M. Ostman, S. Ammoun, K. E. O. Akerman, and J. P. Kukkonen OX1 Orexin Receptors Couple to Adenylyl Cyclase Regulation via Multiple Mechanisms J. Biol. Chem., February 25, 2005; 280(8): 6570 - 6579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen and H. S. Randeva Genomic Organization of Mouse Orexin Receptors: Characterization of Two Novel Tissue-Specific Splice Variants Mol. Endocrinol., November 1, 2004; 18(11): 2790 - 2804. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Kok, F. Roelfsema, S. Overeem, G. J. Lammers, M. Frolich, A. E. Meinders, and H. Pijl Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E630 - E636. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Barreiro, R. Pineda, V. M. Navarro, M. Lopez, J. S. Suominen, L. Pinilla, R. Senaris, J. Toppari, E. Aguilar, C. Dieguez, et al. Orexin 1 Receptor Messenger Ribonucleic Acid Expression and Stimulation of Testosterone Secretion by Orexin-A in Rat Testis Endocrinology, May 1, 2004; 145(5): 2297 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mazzocchi, L. K. Malendowicz, F. Aragona, R. Spinazzi, and G. G. Nussdorfer Cholecystokinin (CCK) Stimulates Aldosterone Secretion from Human Adrenocortical Cells via CCK2 Receptors Coupled to the Adenylate Cyclase/Protein Kinase A Signaling Cascade J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1277 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Johren, N. Bruggemann, A. Dendorfer, and P. Dominiak Gonadal Steroids Differentially Regulate the Messenger Ribonucleic Acid Expression of Pituitary Orexin Type 1 Receptors and Adrenal Orexin Type 2 Receptors Endocrinology, April 1, 2003; 144(4): 1219 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xu, Q. Wang, M. Yan, M. Hernandez, C. Gong, W. C. Boon, Y. Murata, Y. Ueta, and C. Chen Orexin-A Augments Voltage-Gated Ca2+ Currents and Synergistically Increases Growth Hormone (GH) Secretion with GH-Releasing Hormone in Primary Cultured Ovine Somatotropes Endocrinology, December 1, 2002; 143(12): 4609 - 4619. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kukkonen, T. Holmqvist, S. Ammoun, and K. E. O. Akerman Functions of the orexinergic/hypocretinergic system Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1567 - C1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Randeva, E. Karteris, D. Grammatopoulos, and E. W. Hillhouse Expression of Orexin-A and Functional Orexin Type 2 Receptors in the Human Adult Adrenals: Implications for Adrenal Function and Energy Homeostasis J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4808 - 4813. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mazzocchi, L. K. Malendowicz, F. Aragona, P. Rebuffat, L. Gottardo, and G. G. Nussdorfer Human Pheochromocytomas Express Orexin Receptor Type 2 Gene and Display an in Vitro Secretory Response to Orexins A and B J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4818 - 4821. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Karteris, H. S. Randeva, D. K. Grammatopoulos, R. B. Jaffe, and E. W. Hillhouse Expression and Coupling Characteristics of the CRH and Orexin Type 2 Receptors in Human Fetal Adrenals J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4512 - 4519. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Johren, S. J. Neidert, M. Kummer, A. Dendorfer, and P. Dominiak Prepro-Orexin and Orexin Receptor mRNAs Are Differentially Expressed in Peripheral Tissues of Male and Female Rats Endocrinology, August 1, 2001; 142(8): 3324 - 3331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |